References
- A.O.A.C. (1995) Official methods of analysis. 14th ed. Association of official analytical chemists. Washington DC, USA
- Centers for disease control and prevention (1999) Diabetes surveillance report. GA: US Department of Health and Human Services. Atlanta
- Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Seaton TB, Beisswenger P, McGill JB (1995) Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. Diabetes Care. 18:817-824 https://doi.org/10.2337/diacare.18.6.817
- Fujita H, Yamagami T (2001) Fermented soybean-derived touchiextract with anti-diabetic effect via alpha-glucosidase inhibitory action in a long-term administration study with KKAy mice. Life Sci. 70:219-227 https://doi.org/10.1016/S0024-3205(01)01381-9
- Gonuth SM (1973) Plasma insulin and glucose profiles in normal, obese and diabetic persons. Ann. Intern. Med. 79:812-822 https://doi.org/10.7326/0003-4819-79-6-812
- Hanefeld M (1998) The role of acarbose in the treatment of noninsulin- dependent diabetes mellitus. J. Diabetes Complicat. 12:228-237 https://doi.org/10.1016/S1056-8727(97)00123-2
- Hermansen K (2001) Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care. 24:228-233 https://doi.org/10.2337/diacare.24.2.228
- Hillebrand I, Boehme K, Frank G (1979) The effects of the alpha-glucosidase inhibitor BAYg5421(Acarbose) on mealstimulated elevations of circulating glucose, insulin and triglyceride levels in man. Res. Exp. Med. 175:81-86 https://doi.org/10.1007/BF01851236
- Holman RR, Cull CA, Turner RC (1999) A randomized doubleblind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years. (U.K. Prospective Diabetes Study 44). Diabetes Care. 22:960-964 https://doi.org/10.2337/diacare.22.6.960
- Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The framingum study. J.A.M.A. 241:2035-2038 https://doi.org/10.1001/jama.241.19.2035
- King H, Aubert RE, Herman WH (1998) Global burden of diabetes. 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 21:1414-1431 https://doi.org/10.2337/diacare.21.9.1414
- Koivisto VA (1993) Insulin therapy in type II diabetes. Dia-betes Care. 16:29-39 https://doi.org/10.2337/diacare.16.3.29
- Korea National Statistical Office (2005) The cause of death Statistics 2005. Annual report of on the cause of death statistics. Seoul, Korea
-
Lebovitz HE (1998)
$\alpha$ -Glucosidase inhibitors as agents in the treatment of diabetes. Diabetes Rev. 6:132-145 - Lim SJ, Kim KJ (1995) Hypoglycemic effect of Polygonatum Odoratum var. Pluriflorum Ohwi extract in streptozotocininduced diabetic rats. Korean J. Nutr. 28:727-736
- Lim SJ, Kim PJ (1997) Hypoglycemic and hypotensive effects of Polygonatum odoratum consumption in non-insulin dependent diabetics mellitus patients. Korean J. Soc. Food Sci. 13:47-55
- Meneilly GS, Ryan EA, Radziuk J (2000) Effect of acarbose on insulin sensitivity in elderly patients with diabetes. Diabetes Care. 23:1162-1167 https://doi.org/10.2337/diacare.23.8.1162
- Miettinen H (1998) Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA myocardial infarction register study group. Diabetes Care. 21:69-75 https://doi.org/10.2337/diacare.21.1.69
- Mughal MA, Memon MY, Zardari MK, Tanwani RK, Ali M (2000) Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes. J. Pak. Med. Assoc. 50:152-156
- Musabayane CT, Bwititi PT, Ojewole JA (2006) Effects of oral administration of some herbal extracts on food consumption and blood glucose levels in normal and streptozotocin-treated diabetic rats. Methods Find. Exp. Clin. Pharmacol. 28:223-228 https://doi.org/10.1358/mf.2006.28.4.990202
- Nishioka T, Kawabata J, Aoyama Y (1998) Baicalein, an alphaglucosidase inhibitor from Scutellaria baicalensis. J. Nat. Prod. 61:1413-1415 https://doi.org/10.1021/np980163p
- Oku T, Yamada M, Nakamura M, Sadamori N, Nakamura S (2006) Inhibitory effects of extractives from leaves of Morus alba on human and rat small intestinal disaccharidase activity. Br. J. Nutr. 95:933-938 https://doi.org/10.1079/BJN20061746
- Park Y, Boo HO, Park YL, Cho DH, Lee HH (2007) Antioxidant activity of Momordica charantia L. extract. Korean J. Medicinal Crop Sci. 15:56-61
- Prosky L, Asp NG, Schweizer TF, DeVries JW, Furda I (1988) Determination of insoluble, soluble, and total dietary fiber in foods and food products: interlaboratory study. J. Assoc. Off. Anal. Chem. 71:1017-1023
- Qualmann C, Nauck MA, Holst JJ, Orskov C, Creutzfeldt W (1995) Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). Scand. J. Gastroenterol. 30:892-896 https://doi.org/10.3109/00365529509101597
- Seifarth C, Bergmann J, Holst JJ, Ritzel R, Schmiegel W, Nauck MA (1998) Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in type 2 diabetic patients. Diabet. Med. 15:485-491 https://doi.org/10.1002/(SICI)1096-9136(199806)15:6<485::AID-DIA610>3.0.CO;2-Y
- Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 16:434-444 https://doi.org/10.2337/diacare.16.2.434
- Stand E, Baumgartl HJ, Fchtenbusch M, Stemplinger J (1999) Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy. Diabetes Obes. Metab. 1:215-220 https://doi.org/10.1046/j.1463-1326.1999.00021.x
- The diabetes control and complications trial research group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:977-986 https://doi.org/10.1056/NEJM199309303291401
- Toeller M (1994) Alpha-Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects. Eur. J. Clin. Invest. 24(S). 3:31-35
- UK Prospective diabetes study (UKPDS) Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 352:837-853 https://doi.org/10.1016/S0140-6736(98)07019-6
- Wang BT, Cheng YH (2006) Xinbian meirong bencao. Military medicine science publishing co., China
-
Watanabe J, Kawabata J, Kurihara H, Niki R (1997) Isolation and identification of
$\alpha$ -glucosidase inhibitors from Tochu-cha. Biosci. Biotechi. Biochem. 61:177-178 https://doi.org/10.1271/bbb.61.177 - Wright BE, Vasselli JR, Katovich MJ (1998) Positive effects of acarbose in the diabetic rat are not altered by feeding schedule. Phys. Behavior. 63:867-874 https://doi.org/10.1016/S0031-9384(98)00013-4
- Zavaroni I, Reaven GM (1981) Inhibition of carbohydrateinduced hypertriglyceridemia by a disaccharidase inhibitor. Metabolism. 30:417-420 https://doi.org/10.1016/0026-0495(81)90125-6